Literature DB >> 2565324

The polymorphism of HLA-DR3 in South African populations.

M Oudshoorn1, R W Martell, S D Crafford, R May, E D du Toit.   

Abstract

The polymorphism of HLA-DR3 was investigated in families and unrelated individuals of three population groups: South African (SA) Negroes, Cape Coloureds and SA Caucasoids. Serological and restriction fragment length polymorphism (RFLP) analysis indicated that DR3 could be subdivided into DRw17 (previously DR3.1) and DRw18 (previously DR3.2). In contrast, the two-dimensional (2-D) gel electrophoresis patterns could not distinguish between the DRB1 gene products of the HLA-DRw17 and DRw18 cells. Two DRB3 variants, correlating with the T-cell defined specificities Dw24 and Dw25 were identified at the genomic and product level. Of ten haplotypes studied with the newly defined HLA-DRw18 specificity, all had the DRB3 RFLP pattern associated with Dw24. HLA-DRw17 was found in all three population groups tested, although in the SA Negroes HLA-DRw18 was the prevalent DR3 subgroup. This subgroup was also present in the Cape Coloureds but was absent in the SA Caucasoids tested. HLA-DRw18 forms part of the most characteristic SA Negro haplotype, Bw42, DQw4, Dw"RSH," while HLA-DRw17 is part of the classic Caucasoid haplotype, B8, DQw2, Dw3.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2565324     DOI: 10.1016/0198-8859(89)90020-7

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  2 in total

1.  C4B gene polymorphisms among African and African-American HLA-Bw42-DRw18 haplotypes.

Authors:  P A Fraser; Z L Awdeh; P Ronco; S Simon; B Moore; D Fici; D Marcus-Bagley; E J Yunis; C A Alper
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

2.  Complotypes in individuals of African origin: frequencies and possible extended MHC haplotypes.

Authors:  P A Fraser; B Moore; R Stein; S Alosco; A H Johnson; D Marcus-Bagley; Z Awdeh; E J Yunis; C A Alper
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.